348 related articles for article (PubMed ID: 18561324)
1. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference.
Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ
Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324
[TBL] [Abstract][Full Text] [Related]
2. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
3. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
[TBL] [Abstract][Full Text] [Related]
4. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer.
Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H
Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591
[TBL] [Abstract][Full Text] [Related]
5. [Role of silencing PRL-3 expression by miRNA interference in the growth of gastric cancer].
Cai SR; Wang Z; Chen CQ; Cui J; Zhang CH; He YL; Zhan WH
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):618-21. PubMed ID: 18844061
[TBL] [Abstract][Full Text] [Related]
6. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis.
Miskad UA; Semba S; Kato H; Yokozaki H
Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.
Li Z; Zhan W; Wang Z; Zhu B; He Y; Peng J; Cai S; Ma J
Biochem Biophys Res Commun; 2006 Sep; 348(1):229-37. PubMed ID: 16875667
[TBL] [Abstract][Full Text] [Related]
8. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
9. Association of EMP1 with gastric carcinoma invasion, survival and prognosis.
Sun G; Zhao G; Lu Y; Wang Y; Yang C
Int J Oncol; 2014 Sep; 45(3):1091-8. PubMed ID: 24920167
[TBL] [Abstract][Full Text] [Related]
10. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
[TBL] [Abstract][Full Text] [Related]
11. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C
Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198
[TBL] [Abstract][Full Text] [Related]
14. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
[TBL] [Abstract][Full Text] [Related]
15. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
Fujimoto D; Goi T; Hirono Y
Int J Oncol; 2017 Feb; 50(2):448-456. PubMed ID: 28035352
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
17. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
Sun GG; Sheng SH; Jing SW; Hu WN
Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
[TBL] [Abstract][Full Text] [Related]
18. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.
Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M
Int J Cancer; 2010 Aug; 127(3):543-54. PubMed ID: 19960436
[TBL] [Abstract][Full Text] [Related]
19. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
[TBL] [Abstract][Full Text] [Related]
20. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
Zhang C; Tian W; Meng L; Qu L; Shou C
J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
